Slashing NIH research guarantees a less healthy, less wealthy America
Amid this volatility, one thing remains clear: NIH grant funding is a valuable, proven investment, economically and in terms of improving human health.
A recent United for Medical Research report shows that in fiscal year 2024, research funded by the NIH generated $94.58 billion in economic activity nationwide, a 156% return on investment. Further, the report shows that NIH funding supported 407,782 jobs nationwide. According to the NIH's own figures, patents derived from work it has funded produce 20% more economic value than other U.S. patents.
These economic returns — including a return on investment that would thrill any startup or stock investor — cannot begin to capture the impact on individuals, families and communities in terms of increased longevity and higher quality of life.
While it is hard to precisely quantify human health improvements resulting from NIH-funded research, there are proxy measures. As one example, a study published in JAMA Health Forum found that NIH funding supported the development of 386 of 387 drugs approved by the Food and Drug Administration from 2010-19. Many of the approved drugs address the most pressing human health concerns of our time, including cancer, diabetes, cardiovascular disease, infectious diseases and neurological disorders such as Parkinson's disease.
Many other NIH-funded advancements represent what is now considered common knowledge, such as the relationship between cholesterol and cardiovascular health, or standard practice, such as screening newborns for serious diseases that may be treatable with early medical intervention. But each of these fundamental aspects of contemporary medicine had to first be discovered, tested and proved. They represent what NIH funding can do — and the type of paradigm-shifting advancements in medicine that are now very much at risk.
Consider the biotechnology industry as one such paradigm shift. In the 1970s, Stanley Cohen and Herbert Boyer were the first scientists to clone DNA and to transplant genes from one living organism to another. This work launched the biotechnology industry.
Two decades later, the NIH and the Department of Energy began a 13-year effort to sequence the human genome, including through university-based research grants. In 2003, the consortium of researchers produced a sequence accounting for 92% of the human genome. In 2022, a group of researchers primarily funded by the NIH's National Human Genome Research Institute produced a complete human genome sequence. This work paved the way for insights into inherited diseases, pharmacogenomics (how genetics affect the body's response to medications) and precision medicine.
NIH funding has also led to major breakthroughs in cancer treatments. In 1948, Sidney Farber demonstrated the first use of a chemotherapy drug, aminopterin, to induce remission in children with acute leukemia. Before Farber's research, which was funded in part by the NIH, children with acute leukemia were unlikely to survive even five years.
Over the years that followed, other modes of cancer treatment such as immunotherapy emerged, first as novel areas of inquiry, followed by drug development and clinical trials. NIH funding supported, among others, the development of CAR T cell therapy, which genetically modifies a patients' own T-cells to fight cancer. CAR T cell therapy has improved outcomes for many patients with persistent blood cancers, and clinical trials are ongoing to discover other cancers that might be treatable with CAR T cell therapies.
For decades, scientists knew that breast cancer could run in families and hypothesized a genetic role. In the 1990s, teams of scientists — supported at least in part by NIH funding — tracked down the BRCA1 and BRCA2 genes responsible for inherited predispositions to breast and other cancers. Today, many people undergo testing for BRCA gene mutations to make informed decisions about prevention, screening and treatment.
These kinds of advancements, along with improvements in detection and screening, have meaningfully reduced cancer mortality rates. After hitting a smoking-related peak in 1991, U.S. mortality rates from all cancers dropped by 34% as of 2022, according to the American Cancer Society. For children with acute leukemias, who had effectively no long-term chance of survival just 75 years ago, the numbers are even more dramatic. The five-year survival rate is now approximately 90% for children with acute lymphocytic leukemia and between 65% and 70% for those with acute myelogenous leukemia.
These examples represent a fraction of the tremendous progress that has occurred through decades of compounding knowledge and research. Reductions in NIH funding now threaten similar breakthroughs that are the prerequisites to better care, better technology and better outcomes in the most common health concerns and diseases of our time.
It is not research alone that is threatened by NIH funding cuts. Researchers, too, face new uncertainties. We have heard firsthand the anxiety around building a research career in the current environment. Many young physician-scientists wonder whether it will be financially viable to build their own lab in the U.S., or to find jobs at research institutions that must tighten their belts. Many medical residents, fellows and junior faculty are considering leaving the U.S. to train and build careers elsewhere. Losing early-career researchers to other fields or countries would be a blow to talent for biomedical research institutions nationwide and weaken the country's ability to compete globally in the biomedical sector.
The effects of decreased NIH funding might not be immediately visible to most Americans, but as grant cancellations and delays mount, there will be a price. NIH funding produces incredible results. Cuts will set scientific research back and result in losses in quality of life and longevity for generations of Americans in years to come.
Euan Ashley is the chair of the Stanford University department of medicine and a professor of medicine and of genetics. He is the author of 'The Genome Odyssey: Medical Mysteries and the Incredible Quest to Solve Them.' Rachel Keranen is a writer in the Stanford department of medicine.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Health Line
5 hours ago
- Health Line
What Are the Causes of Parkinson's Disease?
Key takeaways Parkinson's disease is a nervous system disorder impacting movement and balance, with the exact causes still under investigation, though it's known to involve the loss of dopamine-producing nerve cells in the brain. Genetic factors, environmental exposures (such as pesticides), and the presence of Lewy bodies (abnormal protein clumps in the brain) are all potential contributors to the development of Parkinson's disease. Age and biological sex also influence Parkinson's risk, with advanced age being the most significant risk factor, and individuals assigned male at birth showing a higher susceptibility to the disease. Parkinson's disease is a chronic disorder of the nervous system, which is made up of pathways of cells and neurons that send and receive signals throughout your body. As of 2017, around 1 million people lived with Parkinson's in the United States. And, according to the Parkinson's Foundation, that number is expected to rise to 1.2 million by 2030 — each year, approximately 60,000 new diagnoses occur in the United States. Parkinson's disease is caused by the loss of nerve cells in a part of your brain called the substantia nigra. These cells control the production of the chemical dopamine. Dopamine helps control movement in your body. But when the cells are impaired, less dopamine is produced. This condition isn't fatal, but it can cause severe symptoms that impact everyday movement and mobility. Hallmark symptoms include tremors and trouble with gait and balance. These symptoms develop because the brain's ability to communicate is impaired. Researchers aren't yet certain what causes Parkinson's. Read on to learn more about several factors that may contribute to the condition. The genetics of Parkinson's A 2020 study including 1,676 people with Parkinson's in mainland China suggested that genes play a role in the development of the condition. An estimated 10 to 15 percent of people with Parkinson's have a family history of the condition. In fact, a number of specific genes have been linked to the development of Parkinson's. How do genetics factor into Parkinson's in some families? According to Genetics Home Reference, one possible way is through the mutation of genes responsible for producing dopamine and certain proteins essential for brain function. Some newer research from 2021 indicates that treatments could potentially be tailored to a person's specific genetic background. However, more research has to first be done on genetic forms of the condition. Environmental causes of Parkinson's disease There's some evidence that your environment can play a role in Parkinson's disease. Exposure to certain chemicals has been suggested as a possible link to the condition. These include: pesticides such as insecticides herbicides fungicides It's also possible that Agent Orange exposure may be linked to Parkinson's, according to VA Health Care. Parkinson's has also been potentially linked to drinking well water in some older studies, such as one from 2009. However, a nationwide study from 2020 suggested that may not be the case. More research needs to be done to determine if well water is associated with increased risk. Some research, such as a 2020 study performed in Morocco, also links consuming excessive manganese, a necessary trace mineral, to an elevated risk of Parkinson's disease. Not everyone exposed to these environmental factors develops Parkinson's, though. Some researchers, such as the author of a 2017 study, theorize that a combination of genetics and environmental factors causes Parkinson's. Lewy bodies Lewy bodies are abnormal clumps of proteins found in the brain stem of people with Parkinson's disease. These clumps contain a protein that cells are unable to break down. They surround cells in the brain and, in the process, interrupt the way the brain functions. Clusters of Lewy bodies cause the brain to degenerate over time. This results in decreased motor coordination in people with Parkinson's disease. Loss of dopamine Dopamine is a neurotransmitter chemical that aids in passing messages between different sections of your brain. In people with Parkinson's, the cells that produce dopamine are impaired. Without an adequate supply of dopamine, your brain is unable to properly send and receive messages. This disruption affects the body's ability to coordinate movement and results in trouble with walking and balance. Age and sex factors Aging also plays a role in Parkinson's disease. Advanced age is the most significant risk factor for developing Parkinson's disease, according to a 2014 research review. Scientists believe that brain and dopamine function begin to decline as your body ages, per a 2016 review. This makes a person more susceptible to Parkinson's. A person's sex can also play a role in Parkinson's. According to 2014 research, people assigned male at birth (referred to as 'men' in the study) are more susceptible to developing Parkinson's than those assigned female (referred to as 'women'). The disease also seems to be more aggressive in males, per a 2020 review. Some researchers, including the authors of a 2015 research paper, are looking into whether sex-specific differences decrease with age. Occupations affecting risk Research from 2009 suggested that certain occupations may put a person at greater risk for developing Parkinson's. In particular, Parkinson's disease may be more likely among people who have jobs in welding, agriculture, and industrial work. This may be because they're exposed to toxic chemicals. However, study results have been inconsistent, according to 2010 research. Ultimately, more research needs to be done. Future research Experts have some clues as to why Parkinson's disease develops, but there's still a lot that's unknown. Early detection and treatment are key in minimizing symptoms of Parkinson's. Advanced technologies such as genetic research, stem cell research, and using so-called neurotrophic factors to revive brain cells show promise in exploratory research. Though treatments can help you manage Parkinson's symptoms and improve your quality of life, a cure hasn't yet been found. And more research is needed to identify the exact role that genetics and environment play in causing this disease.
Health Line
5 hours ago
- Health Line
How to Get a Parkinson's Diagnosis
Key takeaways Parkinson's disease is diagnosed through a clinical evaluation, where doctors review medical history, symptoms, and eliminate other potential causes, as there isn't a single definitive test. Key signs of Parkinson's include slow movement, muscle rigidity, tremors, and balance issues, but early non-motor symptoms like sleep disturbances, mood changes, and autonomic dysfunction can appear years before diagnosis. Although blood tests, spinal fluid tests, and imaging can't diagnose Parkinson's, they do help rule out similar conditions; genetic testing and response to levodopa may offer supportive evidence. Parkinson's disease is a movement disorder caused by the loss of dopamine-producing cells in a part of your brain called the substantia nigra. Parkinson's is the second most common neurodegenerative disorder behind Alzheimer's disease. It affects nearly a million people in the United States. No single test can definitively confirm that you have Parkinson's disease. Doctors make a Parkinson's diagnosis clinically, meaning they use their judgment to make the diagnosis after: reviewing your medical history examining your symptoms ruling out conditions that cause similar symptoms Read on to learn more about the symptoms that can be early signs of Parkinson's disease and how a Parkinson's diagnosis is made. What are the signs and symptoms of Parkinson's? Parkinson's disease is a progressive condition, and symptoms tend to get worse over time. The rate of progression varies between people. At first, symptoms tend to be mild enough that they likely won't interfere with your daily life. But people who regularly spend time with you may notice changes in your gait, posture, or facial expressions. Parkinson's symptoms usually start on one side of your body before progressing to both sides. The four primary symptoms of Parkinson's include: slowness of movement (bradykinesia) muscle rigidity tremor postural instability Symptoms vary between individuals. For example, about 25 percent of people with Parkinson's don't experience a tremor. Even if you don't exhibit all the symptoms, you need to have slowness of movement for your doctor to make the diagnosis. Slowness of movement might manifest in numerous ways, such as: reduced blinking rate lack of facial expression trouble initiating movements like standing from a seated position Along with these four primary signs, other early symptoms of Parkinson's can include: soft voice or voice changes small handwriting shuffling steps stooped posture balance problems Parkinson's also commonly causes non-motor symptoms in the early stages. There's substantial evidence that these non-motor symptoms can appear several years before diagnosis, including: dysfunction of autonomic nervous system general body pain fatigue restless sleep mental changes constipation loss of bladder control erectile dysfunction depression anxiety What's next? If you begin to notice these symptoms gradually progressing, developing a treatment plan early is crucial. If you notice any changes in your movement that you believe could be signs of Parkinson's, visit a primary care physician. If they suspect that you may have Parkinson's, they'll refer you to a neurologist who specializes in movement disorders. What are the diagnostic criteria for Parkinson's? Doctors diagnose Parkinson's clinically based on your symptoms and medical history. No individual test can be used to diagnose Parkinson's. Many other neurogenerative conditions can lead to similar symptoms, so your doctor may use a blood test, brain scans, or other tests to rule out other conditions. Medical history and physical exam The process of diagnosing Parkinson's usually begins with the neurologist evaluating your medical history and performing a physical exam. For a formal diagnosis to be made, you need to have a general slowness of movement with either a resting tremor or rigidity. During the physical exam, your doctor will have you perform a series of tests to monitor your movement. An example of a test they might use is a finger tap, where they measure how many times you can tap your finger in 10 to 15 seconds. They will also look for signs that you may have another condition. A group of movement disorders collectively called parkinsonisms can produce symptoms that are indistinguishable from those of Parkinson's but are not the same. Usually, additional tests are needed to rule out these conditions as well. Blood tests and spinal fluid tests A blood test or spinal fluid test can't be used to diagnose Parkinson's. But they can be used to search for certain proteins that indicate you may have another neurodegenerative condition with similar symptoms. The presence of elevated levels of a nerve protein called neurofilament light chain protein may indicate that you have another movement disorder, such as: multiple system atrophy progressive supranuclear palsy corticobasal degeneration Genetic testing Most people who have Parkinson's don't have a family history of the disease. But there does seem to be a genetic link in about 10 percent of cases. Researchers have found that mutations in some genes seem to be linked to the development of Parkinson's, such as: PINK1 PARK7 SNCA LRRK2 If you have a family history of Parkinson's, genetic testing may provide supportive evidence for a Parkinson's diagnosis. Imaging Your doctor may refer you for imaging tests to help rule out conditions similar to Parkinson's. The brain of somebody with Parkinson's looks the same as the brain of a person without the disease when examined with most imaging tests, such as magnetic resonance imaging (MRI). But an MRI can be used to rule out conditions such as normal pressure hydrocephalus or a subcortical stroke. An imaging technique called a DaTscan can be used to identify the loss of dopamine in your brain. This may help medical professionals differentiate between essential tremor and Parkinson's. Response to medication Although it's not used as a primary diagnostic method, if the medication levodopa helps manage your symptoms, it provides supportive evidence that you have Parkinson's. Usually, other movement disorders that cause similar symptoms don't respond to Levodopa or don't respond for long. How can I try to get an early diagnosis? By the time Parkinson's causes noticeable motor symptoms, usually about 50 percent of the cells that produce dopamine in your substantia nigra have already died off. Non-motor symptoms, such as constipation, loss of smell, or restless sleep, often appear before motor symptoms. There's still debate among medical professionals on how long non-motor symptoms may appear before an individual has noticeable changes in their movement. It's thought that they could appear years to decades beforehand. But a formal Parkinson's diagnosis requires the symptom slowness of movement. In the time before this symptom appears, your doctor can't make a Parkinson's diagnosis, but they may alert you that you're at a high risk of developing Parkinson's in the future if these or other symptoms appear at any point. What are my next steps? If your doctor doesn't diagnose Parkinson's, they can help you find out what the best next step is depending on what condition they suspect. In some cases, treatment may be as simple as changing the dosage of a medication that may be leading to Parkinson's-like symptoms. Receiving a Parkinson's diagnosis can be overwhelming. If your diagnosis is confirmed, contact a movement disorder specialist as soon as possible. A specialist can help you develop a strategy to delay the onset of more severe disease and manage symptoms you're already experiencing. Make lifestyle changes Making lifestyle changes may also help you manage your symptoms. Many people find their symptoms flare up during periods of stress. Adding relaxing activities to your daily routine like yoga or meditation may help you minimize flare-ups. Some early research has found that exercise may help slow the progression of Parkinson's by stimulating the production of a molecule called brain-derived neurotrophic factor in your brain. Many gyms now offer boxing classes for people with Parkinson's to help them manage their symptoms. Other forms of exercise are thought to be effective as well, but boxing has become a popular option. Participate in clinical trials Joining a clinical trial can help contribute to Parkinson's research and may even help you with your symptoms by giving you access to state-of-the-art treatment. You can find clinical trials in your area by searching the NIH database. The Michael J. Fox Foundation also offers a clinical trial matching tool on their website. What's the outlook for a Parkinson's diagnosis? No single test can provide enough information for a doctor to diagnose Parkinson's. A doctor can diagnose Parkinson's clinically by examining your symptoms and medical history. They will likely also recommend other tests, such as imaging or blood tests, to rule out conditions that can cause similar symptoms. Parkinson's gets worse over time, but its progression varies in different people. Many people are able to manage their symptoms for many years before experiencing debilitating symptoms.
Health Line
5 hours ago
- Health Line
11 Complications of Parkinson's Disease You Should Know About
Key takeaways Parkinson's disease may lead to difficulty swallowing, which may result in choking or pneumonia. Speech therapy might help manage this complication. Depression and anxiety may occur in Parkinson's disease because of chemical changes in the brain, and these conditions might be treated with antidepressants and therapy. Parkinson's may disrupt cognitive functions, leading to dementia, sleep disorders, and bladder or bowel problems. Lifestyle changes and medical treatments may provide relief. Parkinson's disease is probably best known for its effects on movement. The most apparent symptoms are rigid limbs, slowed movements, and shaking. Less well known are the complications that occur because of various symptoms like depression, sleep disorders, and dementia. Whether you've been diagnosed with Parkinson's, or you have a loved one with the disease, here are 11 complications you should be aware of so you can watch for the warning signs. 1. Difficulty swallowing Difficulty swallowing with Parkinson's is poorly understood. It may involve problems in the brain, peripheral nerves, and muscles. It may also involve a lack of coordination of the muscles and reflexes involved in swallowing. As a result, food can get stuck in your throat. In the later stages of Parkinson's, trouble swallowing can make you choke, or allow food and liquids to leak into your lungs and cause pneumonia. Some people with Parkinson's produce too much or too little saliva. Excess saliva can lead to drooling. Too little saliva can make swallowing uncomfortable. If you have trouble swallowing, schedule an appointment with your doctor. A speech language pathologist can teach you techniques to help foods and liquids go down more easily. 2. Anxiety and depression Up to half of the people with Parkinson's disease have clinical depression at some point in their lives. If you feel down or you've lost interest in life, talk with your doctor. Antidepressants and therapy can help relieve your depression. It's normal to feel anxious or upset when you live with a chronic condition like Parkinson's disease. Yet depression is more than just a byproduct of living with this disease. It can be a direct result of the disease because of chemical changes in the brain. Parkinson's may contribute to depression through its effects on the hormone serotonin, which regulates mood. 3. Dementia Although Parkinson's is mainly a movement disorder, it can also disrupt parts of the brain that control thought and memory. Between 50–80% of people with Parkinson's develop dementia. People with Parkinson's disease develop abnormal protein deposits called Lewy bodies in their brains. These are the same deposits found in people who have dementia with Lewy bodies (DLB). Dementia in Parkinson's disease causes symptoms like: memory loss trouble concentrating poor judgment hallucinations (seeing things that aren't real) delusions (false ideas) irritability sleep disturbances anxiety These symptoms can start several years after the onset of Parkinson's. Some of the same medications that treat Alzheimer's disease and other forms of dementia also help with Parkinson's dementia. 4. Sleep disorders Sleep disorders are common in people with Parkinson's disease. Any of these nighttime issues can disrupt your sleep: trouble falling asleep (insomnia) nightmares acting out dreams (REM sleep behavior disorder) restless legs syndrome (RLS) sleep apnea frequent need to urinate at night (nocturia) confusion at night A sleep specialist can diagnose these issues and recommend treatments to help you sleep more soundly. 5. Bladder and bowel problems Trouble managing urination and bowel movements stems from a problem with messages getting from your brain to your bladder and bowels. Bladder and bowel problems related to Parkinson's disease include: a constant urge to urinate (urge incontinence or overactive bladder) leaking when you laugh, exercise, or sneeze (stress incontinence) frequent need to urinate at night weak urine stream constipation diarrhea stool leakage (fecal incontinence) Making a few lifestyle changes can help improve bowel and bladder issues. For example: Plan bathroom breaks at regular times throughout the day. Increase your fiber and fluid intake. Try a stool softener. Schedule regular appointments with your doctor for an evaluation. Medications and other treatments can help relieve incontinence due to Parkinson's. 6. Involuntary movements (dyskinesia) This complication isn't caused by Parkinson's disease but by the medication used to treat it. People who take high doses of the drug levodopa (or who stay on it for many years) can develop uncontrolled movements such as head shaking, twitching, swaying, or fidgeting. These movements are called dyskinesia. Shifting dopamine levels in your brain causes dyskinesia. When you take levodopa, dopamine levels rise. As the drug wears off, levels drop. Changing your levodopa dose or adding in an extended-release formula drug may help prevent this complication. Speak with your doctor if you take levodopa and are experiencing dyskinesia. 7. Fatigue Difficulty sleeping at night — which is common in people with Parkinson's disease — can make you feel tired during the day. But Parkinson's fatigue isn't your ordinary exhaustion. Some people feel so tired they can barely get out of bed. Taking naps, exercising, and taking your medication as prescribed can all help address this Parkinson's complication. 8. Pain Up to 80 percent of people diagnosed with the disease will experience pain at some point, according to the American Parkinson's Disease Association. A number of factors in Parkinson's disease trigger pain. Causes include muscle contractions and abnormal processing of pain signals in the brain. The pain can be centered in your: shoulders neck back feet It can feel like: aching burning sharp pains pins and needles pulsing Levodopa — the same drug used to manage Parkinson's symptoms — can also help with pain. It relieves the muscle spasms that trigger pain. Other pain treatments include: analgesic pain relievers physical therapy acupuncture exercise, including tai chi and yoga 9. Blood pressure swings You might notice that you get a little dizzy whenever you stand up from a seated or lying position. This symptom is called orthostatic or postural hypotension. It's caused by a drop in blood pressure when you change positions. It affects about 1 in 5 people with Parkinson's, according to the National Parkinson Foundation. Your body has an internal mechanism that adjusts your blood pressure whenever you move. Postural hypotension happens when there is a problem with this mechanism. Some Parkinson's medications can also cause a drop in blood pressure. To avoid sudden drops in blood pressure: Move slowly when going from a seated or lying position to standing. Drink eight glasses of water each day (extra fluid increases blood pressure). Ask your doctor if the dose for any of your medications that could be affecting your blood pressure needs to be adjusted. 10. Impaired sense of smell A reduced sense of smell is a common — but often overlooked — early symptom of Parkinson's disease. Researchers think it's due to nerve damage from the abnormal buildup of the protein alpha-synuclein (or α-synuclein) in parts of the brain that control the sense of smell.
